Rapid Cognitive Decline Evaluation

Initial Assessment

The American College of Radiology recommends an MRI with contrast for patients with rapid cognitive decline, as CT without contrast is insufficient 1
A detailed medication review, especially for anticholinergic agents, benzodiazepines, and opioids, is necessary to rule out reversible causes of cognitive decline 2, 3
The patient's age, 86 years, and initial MMSE score of 26 are risk factors for rapid cognitive decline 4, 5

Urinalysis with culture and sensitivity, complete blood count with differential, and blood glucose and HbA1c tests are necessary to rule out infections and metabolic disorders 3, 6
Electrolyte panel, liver and kidney function tests, and inflammatory markers such as ESR and CRP should also be performed 6, 2
Serological tests, including syphilis and HIV testing, may be necessary in some cases 6

MRI with contrast is essential to rule out acute or subacute infarcts, subdural hematoma, multiple lacunar infarcts, or brain tumors 3, 1, 5
CT without contrast is insufficient for evaluating rapid cognitive decline 5, 2, 3

Lumbar puncture with CSF analysis may be necessary to rule out infectious or inflammatory causes of cognitive decline 6, 3
PET or SPECT scans may be considered for differential diagnosis 6

Factors that contribute to rapid cognitive decline include an initial MMSE score close to the threshold value, age, and a rapid decline over 1 month 4, 5, 3
Delirium should not be overlooked, as it can co-occur with dementia 2, 3

Immediate actions (within 24-48 hours) include a detailed history, physical examination, and basic laboratory tests 3
Within 1 week, an MRI with contrast and extended laboratory tests should be performed 1, 5, 2, 3, 6
If no acute causes are found, lumbar puncture and PET or SPECT scans may be considered 3, 6

Anatomical neuroimaging with MRI is recommended when cognitive symptoms began within the past 2 years, regardless of progression rate, as stated by the Alzheimer's and Dementia guidelines 7
MRI is strongly preferred over CT due to its superior sensitivity for detecting vascular lesions, specific dementia subtypes, and rare conditions that may cause rapid decline, according to the Journal of the American College of Radiology 8
The following MRI sequences are recommended: 3D T1 volumetric sequence with coronal reformations for hippocampal assessment, Fluid-attenuated inversion recovery (FLAIR), T2 or susceptibility-weighted imaging (SWI), and Diffusion-weighted imaging (DWI), as suggested by the Alzheimer's and Dementia guidelines 7

FDG-PET/CT is recommended for differential diagnosis when underlying pathology remains unclear, as stated by the Journal of the American College of Radiology 8